Skip to main content
Top

Chinese Journal of Cancer Research

Issue 4/2010

Content (12 Articles)

Review

Methylation and demethylation of Ink4 locus in cancer development

Da-jun Deng, Qiang Li, Xiu-hong Wang

Original Article

Polymorphisms of UGT1A7 and XRCC1 are associated with an increased risk of hepatocellular carcinoma in Northeast China

Zhi-fang Jia, Hong-ying Su, Xue-lian Li, Xin Xu, Zhi-hua Yin, Peng Guan, Bao-sen Zhou

Original Article

Risk factors of precancerous gastric lesions in a population at high risk of gastric cancer

Jian Liu, Li-Ping Sun, Yue-Hua Gong, Yuan Yuan

Original Article

Stanniocalcin-1 detection of peripheral blood in patients with colorectal cancer

Wu Ping-ping, Wu Peng, Huang Pei-lin, Long Qi-qiang, Bu Xiao-dong

Original Article

Promoter hypermethylation of KiSS-1 gene in gastric cancer

Zhi Yang, Dong-Qiu Dai, Yun-Yi Du

Original Article

Recurrent patterns and factors involved in node-negative advanced gastric cancer

En-Yi Liu, Mei-Zuo Zhong, Cai-Gang Liu, Jin Huang, Wei Liu, Shan Zeng, Bin Li, Jing-Chen Lu, Jian-Huang Li, Hai-Rong Jiang

Original Article

High expression of ERCC1 is a poor prognostic factor in Chinese patients with non-small cell lung cancer receiving cisplatin-based therapy

Qing-zhi Guo, Jie Wang, Hua Bai, Tong-tong An, Meina Wu, Jun Zhao, Lu Yang, Jian-chun Duan, Yu-yan Wang, Zhi-jie Wang

Original Article

Interleukin-18 suppresses angiogenesis and lymphangiogenesis in implanted Lewis lung cancer

Sheng Yang, Xiang-qi Chen, Hui-shan Lu, Zhi-ying Li, Ting-yan Lin

Original Article

Decrease of peripheral blood CD8+/CD28-suppressor T cell followed by dentritic cells immunomodulation among metastatic breast cancer patients

Guo-hong Song, Jun Ren, Lijun Di, Jing Yu, Jie Zhang, Bin Shao, Jun Jia, Wei Sun

Original Article

Inhibition of proliferation induced by cyclin D1 gene silence in human renal carcinoma ACHN cells

Jiang Wang, Feng-jin Guo, An-min Chen, Cai-hong Yang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine